{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:07:14Z","timestamp":1761487634259,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.tmaid.2004.12.002","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T10:16:12Z","timestamp":1107857772000},"page":"38-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oral cholera vaccine\u2014for whom, when, and why?"],"prefix":"10.1016","volume":"4","author":[{"given":"Maureen H.","family":"Topps","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2004.12.002_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/313951","article-title":"Cholera vaccines","volume":"31","author":"Ryan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2004.12.002_bib2","first-page":"2","article-title":"Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Vietnam","volume":"80","author":"Trach","year":"2002","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2004.12.002_bib3","article-title":"Vaccines for preventing cholera","author":"Graves","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmaid.2004.12.002_bib4","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/oxfordjournals.aje.a009385","article-title":"Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines","volume":"147","author":"Durham","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.tmaid.2004.12.002_bib5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/infdis\/166.5.1029","article-title":"Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area","volume":"166","author":"Clemens","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2004.12.002_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0264-410X(95)00122-H","article-title":"Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up","volume":"14","author":"van Loon","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2004.12.002_bib7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(94)90755-2","article-title":"Protective efficacy of oral whole-cell\/recombinant-B-subunit cholera vaccine in Peruvian military recruits","volume":"344","author":"Sanchez","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2004.12.002_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(97)22004-0","article-title":"Oral vaccines against cholera: lessons from Vietnam and elsewhere","volume":"349","author":"Levine","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2004.12.002_bib9","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1128\/IAI.67.12.6341-6345.1999","article-title":"Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba three months after vaccination","volume":"67","author":"Tacket","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.tmaid.2004.12.002_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11894-001-0054-z","article-title":"New developments in the understanding of cholera","volume":"3","author":"Butler","year":"2001","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.tmaid.2004.12.002_bib11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(95)90698-3","article-title":"Immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype","volume":"345","author":"Coster","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2004.12.002_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2004.12.002_bib13","first-page":"304","article-title":"Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam","volume":"21","author":"Vu","year":"2003","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.tmaid.2004.12.002_bib14","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(94)90744-7","article-title":"New cholera vaccines\u2014for whom?","volume":"344","author":"Steffen","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2004.12.002_bib15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jama.280.7.600-a","article-title":"Cholera vaccine in refugee settings","volume":"280","author":"Sack","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2004.12.002_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jama.279.7.521","article-title":"Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis","volume":"279","author":"Naficy","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2004.12.002_bib17","first-page":"343","article-title":"Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera","volume":"76","author":"Murray","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2004.12.002_bib18","first-page":"317","article-title":"Safe water for travellers","volume":"169","author":"Krym","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.tmaid.2004.12.002_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0891-5520(20)30445-1","article-title":"Prevention of traveler's diarrhea","volume":"6","author":"Tellier","year":"1992","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.tmaid.2004.12.002_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/ije\/14.1.169","article-title":"\u2018Boil it, cook it, peel it or forget it\u2019: does this rule prevent travellers' diarrhoea?","volume":"14","author":"Kozicki","year":"1985","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.tmaid.2004.12.002_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1708-8305.1995.tb00631.x","article-title":"Risk behavior for travelers' diarrhea among finnish travelers","volume":"2","author":"Mattila","year":"1995","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2004.12.002_bib22","first-page":"1947","article-title":"Cholera vaccination: a decision analysis","volume":"146","author":"MacPherson","year":"1992","journal-title":"CMAJ"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893905000049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893905000049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:56:08Z","timestamp":1761486968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893905000049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1477893905000049"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2004.12.002","relation":{},"ISSN":["1477-8939"],"issn-type":[{"type":"print","value":"1477-8939"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral cholera vaccine\u2014for whom, when, and why?","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2004.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}